BBIXF Stock - Bonus BioGroup Ltd.
Unlock GoAI Insights for BBIXF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | $-3,366,000 | $-4,097,000 | $-1,609,000 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-27,836,000 | $-29,790,000 | $-37,047,000 | $-64,735,000 | $-19,444,000 |
| Net Income | $-27,826,000 | $-28,529,000 | $-38,703,000 | $-90,076,000 | $-22,021,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.02 | $-0.02 | $-0.03 | $-0.08 | $-0.02 |
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. It develops tissue-regenerating bone grafts from cells derived from the patient's own cells for the treatment of skeletal disorders, such as bone trauma and arthritis. The company's products include BonoFill injectable bone graft that is suitable for bone repair applications, including jaw bone cysts; and BonoFill pre-designed bone graft, which is used to repair large and segmental bone defects. Its products in pipeline comprise bone grafts for maxillofacial and orthopedic applications; novel nanomaterials technology for tissue regeneration; and large vascularized bone grafts. The company was formerly known as Oceana Advanced Industries Ltd. and changed its name to Bonus BioGroup Ltd. Bonus BioGroup Ltd. was founded in 1981 and is based in Haifa, Israel.
Visit WebsiteEarnings History & Surprises
BBIXFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Dec 31, 2024 | — | $-0.00 | — | — |
Q4 2024 | Nov 13, 2024 | — | $-0.00 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 31, 2024 | — | $-0.00 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.00 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.00 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.00 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.00 | — | — |
Latest News
Frequently Asked Questions about BBIXF
What is BBIXF's current stock price?
What is the analyst price target for BBIXF?
What sector is Bonus BioGroup Ltd. in?
What is BBIXF's market cap?
Does BBIXF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to BBIXF for comparison